Author

Fatima Amor

Inserm

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Genetics· 1 Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Organism:mouse· 2 Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Approach:statistical model· 1

Frequent Co-Authors

Isabelle RichardiD· 2 shared Ai Vu HongiD· 1 shared Anne De CianiD· 1 shared David IsraeliiD· 1 shared Fetta MazediD· 1 shared Francesco Saverio TedescoiD· 1 shared Giuseppe RonzittiiD· 1 shared Guillaume CorreiD· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMolecular Biology

Isabelle RichardORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

CRISPR-Cas9 mediated endogenous utrophin upregulation improves Duchenne Muscular Dystrophy

Simon Guiraud, Sumitava Dastidar, Fetta Mazed, Fatima Amor, Maëlle Ralu, Anne De Cian, Isabelle Richard, Giuseppe Ronzitti, Francesco Saverio Tedesco, Mario Amendola

This study uses CRISPR-Cas9 to disrupt miR binding sites and upregulate utrophin in DMD models, showing functional improvements and therapeutic potential.

bioRxiv · Apr 18, 2023 · PreprintMolecular Biology

Cholesterol metabolism is a potential therapeutic target in Duchenne Muscular Dystrophy

Fatima Amor, Ai Vu Hong, Guillaume Corre, Mathilde Sanson, Laurence Suel, S. Blaie, Laurent Servais, Thomas Voït, Isabelle Richard, David Israeli

This study identifies dysregulated miRNAs in DMD patients and mice, linking cholesterol metabolism and the mevalonate pathway to disease progression, with Simvastatin treatment showing therapeutic potential.

Journal of Cachexia Sarcopenia and Muscle · May 26, 2021Peer-reviewedGenetics